Clinical Trials Directory

Trials / Completed

CompletedNCT05205512

Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors, TECHS Trial

Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors (TECHS): A Pilot Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
City of Hope Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical trial tests how well a telehealth exercise intervention works to improve cardiovascular health in lymphoma survivors. Telehealth exercise is a service to help perform physical exercises at home with a care provider online. With the use of telehealth exercise lymphoma survivors may be able to participate in exercise programs safely to improve heart health and reduce the risk of cardiovascular disease.

Detailed description

PRIMARY OBJECTIVE: I. Determine the feasibility of an 8-week telehealth exercise intervention, as assessed by enrollment, retention, and adherence to the telehealth exercise intervention. SECONDARY OBJECTIVE: I. Explore the effects of an 8-week telehealth exercise intervention on cardiovascular health, assessed by cardiopulmonary exercise test, pulmonary function test, body compositions, and blood biomarkers. OUTLINE: Participants are randomized into 1 of 2 groups. GROUP I (TELEHEALTH EXERCISE): Patients participate in telehealth exercise intervention for 30 minutes per day, 3 days a week for 8 weeks. GROUP II (DELAYED CONTROL): Patients maintain current levels of physical activity for 8 weeks. Patients may then participate in telehealth exercise intervention for 8 weeks. After completion of study treatment, participants are followed up after 1 week.

Conditions

Interventions

TypeNameDescription
OTHERExercise InterventionMaintain current levels of physical activity
OTHERQuestionnaire AdministrationAncillary studies
OTHERTelemedicineParticipate in telehealth exercise intervention

Timeline

Start date
2022-09-14
Primary completion
2025-06-09
Completion
2025-06-09
First posted
2022-01-25
Last updated
2025-10-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05205512. Inclusion in this directory is not an endorsement.